NCT02988960 2026-01-09A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsAbbViePhase 1 Active not recruiting163 enrolled
NCT03893955 2025-08-12A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsAbbViePhase 1 Active not recruiting150 enrolled